Onderneming Argenica Therapeutics Limited
Aandelen
AGN
AU0000150328
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,565 AUD | +0,89% | -0,88% | +10,78% |
16/04 | ARGENICA THERAPEUTICS LIMITED : Euroz Hartleys herhaalt koopadvies | ZM |
28/03 | Argenica Therapeutics doneert eerste patiënt in Fase Twee Studie naar Beroerte; Aandelen stijgen met 14% | MT |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Liz Dallimore
CEO | Chief Executive Officer | - | - |
Emma Waldon
DFI | Director of Finance/CFO | - | - |
Meghan Thomas
CTO | Chief Tech/Sci/R&D Officer | - | 04-04-22 |
Bruno Meloni
CTO | Chief Tech/Sci/R&D Officer | - | - |
Celina Chewas
PRN | Corporate Officer/Principal | - | 22/11 |
Samantha South
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Terry C. Budge
BRD | Director/Board Member | 72 | - |
Geoff Pocock
BRD | Director/Board Member | - | - |
Dianne Angus
BRD | Director/Board Member | 63 | 01/12 |
McCall Liddy
BRD | Director/Board Member | - | - |
Samantha South
PRN | Corporate Officer/Principal | - | - |
Liz Dallimore
CEO | Chief Executive Officer | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 99 150 822 | 87 682 620 ( 88,43 %) | 0 | 88,43 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,78% | 45,25 mln. | |
+1,51% | 42,75 mld. | |
+8,57% | 41,34 mld. | |
+49,22% | 41,61 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |